Germany Stock Screener - Compare & Analyze Key Metrics
Discover and filter top-performing stocks in the Germany market. Analyze key metrics like market cap, P/E ratio, revenue growth, and more for smarter investment decisions. Track Global Market Trends from Germany with Our Tools.
| Code |
Company Name | Stock Price | Sector | Market Cap | P/E Ratio | Forward P/E | Volume | Return on Equity | Revenue |
|---|---|---|---|---|---|---|---|---|---|
|
|
XPS Pensions Group plc | €4.19 | Consumer Cyclical | €- | - | - | 100.00 | 0.38 | €263.04 Million |
|
|
XPS Pensions Group plc | €4.44 | - | €- | - | - | 0.00 | - | €- |
|
|
XRF SCIENTIFIC | €0.17 | Other | €- | - | - | 0.00 | - | €- |
|
|
XSLE | €38.06 | - | €- | - | - | 0.00 | - | €- |
|
|
XSLR | €44.27 | - | €- | - | - | 0.00 | - | €- |
|
|
XSPRAY PHARMA AB | €2.59 | - | €- | - | - | 379.00 | - | €- |
|
|
XSTATE RESOURCES | €0.06 | Other | €- | - | - | 0.00 | - | €- |
|
|
XTB SA | €15.17 | - | €- | - | - | 0.00 | - | €- |
|
|
XTL Biopharmaceuticals Ltd. | €0.98 | - | €- | - | - | 0.00 | - | €- |
|
|
XTL Biopharmaceuticals Ltd. | € | Healthcare | €- | - | - | - | -0.26 | €42.40K |
|
|
XTM Inc. | € | Technology | €- | - | - | 2.01 Million | 2.19 | €5.27 Million |
|
|
XTM Inc. | €0.03 | - | €- | - | - | 0.00 | - | €- |
|
|
XTM Inc. | €0.02 | - | €- | - | - | 0.00 | - | €0.00 |
|
|
XTPL S.A. | €25 | - | €- | - | - | 0.00 | - | €- |
|
|
XTPL SA | €24.55 | - | €- | - | - | 0.00 | - | €0.00 |
|
|
XTR P GOLD EUR 60 | €267.70 | - | €- | - | - | 5.00 | - | €0.00 |
|
|
XTR P GOLD EUR H60 | €175.65 | - | €- | - | - | 315.00 | - | €0.00 |
|
|
XTR P PLATINUM EUR H60 | €52.97 | - | €- | - | - | 400.00 | - | €0.00 |
|
|
XTR P SILVER EUR 60 | €285.40 | - | €- | - | - | 25.00 | - | €0.00 |
|
|
XTR P SILVER EUR H60 | €177.89 | - | €- | - | - | 2.00 | - | €0.00 |
57641 - 57660 of 58545 stocks in Germany
Data Sources
Market data for Germany stocks is sourced from multiple exchanges including BA, BE, DU, F, FSX, HA, HM, MU, Munich, STU, XBER, XDUS, XETR, XETRA, XHAM, XHAN, XSTU . Our financial data is compiled from official company filings, including quarterly (10-Q) and annual (10-K) reports submitted to regulatory authorities, along with earnings releases and direct disclosures from company investor relations departments. Market prices are updated continually during trading hours, while fundamental data is refreshed daily after market close to reflect the latest financial statements and corporate actions. News and corporate events are monitored and updated in real-time to provide comprehensive coverage of market-moving developments. All financial metrics, ratios, and analysis are calculated using standardized methodologies to ensure consistency across different companies and markets.